Company Profiles

driven by the PitchBook Platform

Integene International

2010 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$300k LATEST DEAL AMOUNT
$300k TOTAL AMOUNT RAISED
3 INVESTORS
Description

Developer of a platform technology for treatments of vascular diseases. The company develops a technology for the treatment of cardiovascular ischemic disease using combinations of gene and stem cell procedures.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
1951 North West 7th Avenue
Suite 300
Miami, FL 33136
United States

+1 (813) 545-8783
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Integene International’s full profile, request a free trial.

Integene International Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 13-Aug-2014 $300k $300k Completed Startup
2. Angel (individual) Completed Startup
1. Grant $10M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Integene International Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Florida Institute for the Commercialization of Public Research University Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0

Integene International Executive Team (3)

Name Title Board
Seat
Contact
Info
Jimmy DeMesa MD Chief Executive Officer
Keith Webster Ph.D Chief Scientific Officer and Founder
Michael Gold Executive Chairman

Integene International Board Members (3)

Name Representing Role Since Contact
Info
Eduardo De Marchenna MD Integene International Board Member 000 0000
Marvin Sackner MD Integene International Board Member 000 0000
Michael Gold Integene International Executive Chairman 000 0000